相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bioengineering the Liver: Scale-Up and Cool Chain Delivery of the Liver Cell Biomass for Clinical Targeting in a Bioartificial Liver Support System
Eloy Erro et al.
BIORESEARCH OPEN ACCESS (2013)
Proliferative human cell sources applied as biocomponent in bioartificial livers: a review
Geert A. A. Nibourg et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Bridging the gap: Advances in artificial liver support
Scott L. Nyberg
LIVER TRANSPLANTATION (2012)
Liver Progenitor Cell Line HepaRG Differentiated in a Bioartificial Liver Effectively Supplies Liver Support to Rats with Acute Liver Failure
Geert A. A. Nibourg et al.
PLOS ONE (2012)
1080 OXYGEN CARRIERS FOR BIOMASS PRESERVATION DURING THE TRANSPORT OF A BIOARTIFICIAL LIVER
E. Erro et al.
JOURNAL OF HEPATOLOGY (2011)
Fractionated plasma separation and adsorption: current practice and future options
Kinan Rifai
LIVER INTERNATIONAL (2011)
Industrial Stabilizers Caprylate and N-Acetyltryptophanate Reduce the Efficacy of Albumin in Liver Patients
Jan Stange et al.
LIVER TRANSPLANTATION (2011)
Cryopreservation of Encapsulated Liver Spheroids for a Bioartificial Liver: Reducing Latent Cryoinjury Using an Ice Nucleating Agent
Isobel Massie et al.
TISSUE ENGINEERING PART C-METHODS (2011)
Evaluation of coagulation stages of hemorrhaged swine: comparison of thromboelastography and rotational elastometry
Toshiki Tomori et al.
BLOOD COAGULATION & FIBRINOLYSIS (2010)
1184 EXTRACORPOREAL LIVER SUPPORT WITH THE MOLECULAR ADSORBENT RECIRCULATING SYSTEM (MARS) IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (AOCLF). THE RELIEF TRIAL
R. Bañnares et al.
JOURNAL OF HEPATOLOGY (2010)
OPTIMIZATION OF THE BIOMASS GROWTH FOR THE DEVELOPMENT OF A CLINICAL SCALE BIOARTIFICIAL LIVER USING A HUMAN DERIVED CELL LINE WITHIN ENCAPSULATED ALGINATE
E. Erro et al.
JOURNAL OF HEPATOLOGY (2010)
SAFETY AND EFFICACY OF THE EXTRACORPOREAL LIVER ASSIST DEVICE (ELAD (R)) IN PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE
D. J. Hillebrand et al.
JOURNAL OF HEPATOLOGY (2010)
Alginate-encapsulated HepG2 Cells in a Fluidized Bed Bioreactor Maintain Function in Human Liver Failure Plasma
Sam M. Coward et al.
ARTIFICIAL ORGANS (2009)
Artificial and bioartificial liver devices: present and future
B. Carpentier et al.
GUT (2009)
Pig thrombomodulin binds human thrombin but is a poor cofactor for activation of human protein C and TAFI
J. C. Roussel et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs
Wenjun Z. Martini et al.
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2008)
Cells for bioartificial liver devices: The human hepatoma-derived cell line C3A produces urea but does not detoxify ammonia
Demetra Mavri-Damelin et al.
BIOTECHNOLOGY AND BIOENGINEERING (2008)
Standardization criteria for an ischemic surgical model of acute hepatic failure in pigs
M Nieuwoudt et al.
BIOMATERIALS (2006)
Proliferation rates of HepG2 cells encapsulated in alginate are increased in a microgravity environment compared with static cultures
SM Coward et al.
ARTIFICIAL ORGANS (2005)
Alginate-encapsulated human hepatoblastoma cells in an extracorporeal perfusion system improve some systemic parameters of liver failure in a xenogeneic model
TM Rahman et al.
ARTIFICIAL ORGANS (2004)
Extracorporeal liver support based on primary human liver cells and albumin dialysis - treatment of a patient with primary graft non-function
IM Sauer et al.
JOURNAL OF HEPATOLOGY (2003)
Standardization of ischemic hepatic failure in pigs as a model for bioartificial liver assessment
T Miyashita et al.
SURGERY TODAY (2003)
Assessment of the AMC-bioartificial liver in the anhepatic pig
MN Sosef et al.
TRANSPLANTATION (2002)
Human hepatocyte cell lines proliferating as cohesive spheroid colonies in alginate markedly upregulate both synthetic and detoxificatory liver function
M Khalil et al.
JOURNAL OF HEPATOLOGY (2001)
分享论文
